News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Data on Chimerix, Inc.'s CMX001 Selected for Two Oral Presentations at the 26th International Conference on Antiviral Research


5/10/2013 9:17:57 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DURHAM, N.C., May 10, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced two oral presentations related to its broad-spectrum antiviral compound CMX001 at the International Society for Antiviral Research's 26th International Conference on Antiviral Research (ICAR). ICAR is being held May 11-15, 2013 at the Hyatt Regency in San Francisco, CA.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES